StockStory.org on MSN4d
3 Reasons Investors Watch United Therapeutics (UTHR)United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop.
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend ...
Commonwealth Equity Services LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 3.7% during ...
In trading on Wednesday, shares of United Therapeutics Corp (Symbol: UTHR) entered into oversold territory, hitting an RSI reading of 28.5, after changing hands as low as $319.02 per share.
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief ...
Coming in No. 3 on Fast Company's Queer 50 list, is Martine Rothblatt, the founder and CEO of United Therapeutics. She's also a lawyer, satellite entrepreneur, and futurist. See the innovative ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the ...
In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most expensive stocks insiders are dumping in March. After being in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results